Fortrea Holdings Inc. Common Stock
FTREFortrea Holdings Inc. (FTRE) is a global contract research organization (CRO) that provides clinical development services to the biopharmaceutical and healthcare industries. The company offers a range of solutions including clinical trial management, data management, biostatistics, and regulatory consulting, supporting the development of new drugs and treatments. Fortrea is focused on delivering innovative and efficient clinical research services to accelerate pharmaceutical development worldwide.
Company News
Grabar Law Office is investigating potential securities fraud and fiduciary breaches for several publicly traded companies, alleging misleading statements and undisclosed business risks that potentially harmed shareholders.
Fortrea announced granting 245,000 restricted stock units (RSUs) to two newly hired employees, with vesting occurring in three equal annual installments starting December 10, 2026.
Grabar Law Office is investigating potential securities fraud and fiduciary duty breaches for several publicly traded companies, alleging misleading statements and incomplete disclosures that potentially harmed shareholders.
Fortrea has completed a debt tender offer, purchasing $75.7 million of its outstanding 7.500% Senior Secured Notes due 2030, reducing the principal outstanding from $570 million to $494.3 million.
Law firm Grabar Law Office is investigating potential securities fraud and fiduciary duty breaches for four publicly traded companies, alleging misleading statements and undisclosed material facts that impacted investor interests.
